PUBLISHER: The Business Research Company | PRODUCT CODE: 1939185
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939185
Ablation devices are medical instruments used to eliminate abnormal tissue growths or dysfunctional cells, such as tumors or cardiac arrhythmias, employing various energy sources such as heat, cold, or radiofrequency. These devices play a crucial role in minimally invasive procedures aimed at treating conditions ranging from cancer to heart rhythm disorders.
The primary types of ablation devices include laser ablators, radiofrequency ablators, microwave ablators, ultrasound ablators, electric ablators, hydrothermal ablators, and cryoablators. Laser ablators utilize laser energy for precise material removal or modification, commonly applied in industrial settings. The technology encompasses various methods such as radiofrequency ablation, microwave ablation, cryoablation, high-intensity focused ultrasound, laser interstitial thermal ablation, and others, often incorporating automated and robotic functionalities. These devices are utilized by diverse end-users including hospitals, clinics, ambulatory surgical centers, and others.
Tariffs are impacting the ablation devices market by increasing import and component acquisition costs for electronic controllers, semiconductor modules, optical assemblies, and energy-delivery components used in laser, radiofrequency, microwave, ultrasound, cryoablation, and electrosurgical systems. Higher duties particularly affect regions relying on cross-border sourcing from Asia-Pacific and Europe, influencing procurement budgets for hospitals, clinics, and ambulatory surgical centers. However, tariffs are also encouraging localized manufacturing, regional supplier development, and cost-optimized product engineering, which support supply-chain resilience and stimulate innovation in next-generation ablation technologies.
The ablation devices market research report is one of a series of new reports from The Business Research Company that provides ablation devices market statistics, including ablation devices industry global market size, regional shares, competitors with a ablation devices market share, detailed ablation devices market segments, market trends and opportunities, and any further data you may need to thrive in the ablation devices industry. This ablation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ablation devices market size has grown strongly in recent years. It will grow from $9.25 billion in 2025 to $10.12 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to increasing prevalence of cancer treatment procedures, rising adoption of ablation in cardiac arrhythmia management, growth in hospital installation of radiofrequency and laser ablation systems, expanding clinical acceptance of minimally invasive therapy alternatives, increasing usage of cryoablation and microwave ablation in specialty care.
The ablation devices market size is expected to see strong growth in the next few years. It will grow to $14.02 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to rising demand for precision targeted tissue ablation technologies, growing adoption of robotic and automatic ablation systems, expansion of ablation applications across multiple therapeutic areas, increasing investment in outpatient and ambulatory surgical infrastructure, rising preference for minimally invasive procedures with faster recovery. Major trends in the forecast period include increasing adoption of minimally invasive ablation procedures across oncology and cardiology, rising utilization of radiofrequency and microwave ablation systems for targeted tissue destruction, growing preference for cryoablation and hydrothermal ablation in specialized clinical applications, expanding clinical use of laser and ultrasound ablation devices for precision therapeutic outcomes, increasing deployment of ablation technologies in ambulatory and outpatient surgical settings.
The rising incidence of cancer is anticipated to drive the growth of the microwave ablation devices market in the coming years. Cancer is a condition characterized by the uncontrolled growth of abnormal cells that can spread to other parts of the body. The increase in cancer cases is largely attributed to longer life expectancy, which raises the risk of age-related diseases such as cancer. Microwave ablation devices are used in cancer treatment by emitting electromagnetic waves that generate heat to destroy tumor cells. This targeted and minimally invasive technique helps preserve surrounding healthy tissue and supports faster patient recovery. For example, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, more than 35 million new cancer cases were projected by 2050, representing a 77% increase compared to the estimated 20 million cases reported in 2022. As a result, the growing number of cancer cases is fueling the expansion of the microwave ablation devices market.
Major companies operating in the microwave ablation devices market are emphasizing the development of advanced products with regulatory approvals, such as high-precision microwave ablation systems, to enhance patient outcomes in minimally invasive cancer treatments. A high-precision microwave ablation system is an advanced medical device that uses focused microwave energy to accurately destroy tumor tissue. It delivers controlled heat to targeted areas while minimizing damage to adjacent healthy structures, thereby improving safety and treatment effectiveness. For instance, in January 2024, Hygea Medical Technology Co. Ltd., a China-based medical device manufacturer, received approval from the Food and Drug Administration (FDA) for its EXCEED microwave treatment system and EXACT series microwave ablation probes. This approval followed prior clearance from China's National Medical Products Administration (NMPA) and was obtained through an expedited review process. The FDA clearance confirms the safety, performance, and quality of Hygea's products for the treatment of various solid tumors in soft tissues, marking a key milestone in the company's international expansion, particularly in the U.S. microwave ablation market. This system complements existing cancer therapies by providing a high-precision, minimally invasive thermal ablation solution.
In July 2024, Creo Medical Group plc, a UK-based manufacturer of flexible microwave ablation devices, entered into a partnership with Intuitive Surgical Inc. to advance minimally invasive lung cancer treatment. The collaboration is intended to integrate Creo's MicroBlate Flex and Kamaptive technologies with Intuitive's Ion Endoluminal System, supporting expanded clinical studies and improving precision in lung cancer diagnosis and ablation across the UK and Europe. Intuitive Surgical Inc. is a US-based provider of minimally invasive care and a pioneer in robotic surgery.
Major companies operating in the ablation devices market are Medtronic plc, Boston Scientific Corporation, Johnson & Johnson, Abbott Laboratories, AngioDynamics Inc, CONMED Corporation, Olympus Corporation, Smith & Nephew plc, AtriCure Inc, Stryker Corporation, Biotronik SE & Co KG, BTG plc, Terumo Corporation, Varian Medical Systems Inc, Hologic Inc, Accuray Inc, Bard Inc, Elekta AB, Misonix Inc, Japan Lifeline Co Ltd
North America was the largest region in the ablation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ablation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the ablation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The ablation devices market consists of sales of medical devices such as irreversible electroporation (IRE) ablators, photodynamic therapy (PDT) ablators, high-intensity focused ultrasound (HIFU) ablators, chemical ablators, and mechanical ablators. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ablation Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses ablation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ablation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ablation devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.